Acelyrin claims errors by CRO Fortrea led to late-stage trial downfall
A Phase IIb/III trial studying the company’s immunotherapy izokibep, failed to achieve statistical significance for its primary endpoint
Emergent wins $75m BARDA contact for anthrax vaccine
Novovax’s Omicron-targeting Covid-19 vaccine obtains WHO emergency listing
Abeona’s cell therapy secures priority approval date for rare skin disorder
Radiopharmaceuticals reach record high with $408m in venture financing for 2023
FDA rejects Aldeyra’s dry eye drug, asks for more clinical data
Analysis
View More
Themes
View MoreBoehringer to leverage IBM’s technologies for antibody discovery
Boehringer will utilise a generative AI model developed by IBM to discover candidate antibodies.
More themes
Premium Insights
View MoreLeading innovators in nucleotide analogues for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover premium insights powered by our properietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Japan approves Daiichi Sankyo’s Covid-19 booster vaccine
IGC Pharma signs agreement to adopt AI solutions into drug discovery
Genentech and NVIDIA enter generative AI-powered drug discovery deal
Daiichi Sankyo signs agreement with Japan to supply Covid-19 vaccine